Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Lingering Uncertainties and Emerging Possibilities-Reference-Cited by-同舟云学术

Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Lingering Uncertainties and Emerging Possibilities

Published:2015-03 Issue:3 Volume:21 Page:412-420
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Mukherjee Sudipto^ORCID,Boccaccio Dominic^ORCID,Sekeres Mikkael A.,Copelan Edward^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference81 articles.

1. SEER cancer statistics review;Howlader,1975

2. Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2013. Available at: http://www.cibmtr.org

3. Reduced mortality after allogeneic hematopoietic-cell transplantation;Gooley;N Engl J Med,2010

4. Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS;Deeg;Blood,2012

5. Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome;Kröger;Blood,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of pretransplant anti‐thymocyte globulin in matched sibling donor stem cell transplantation after reduced intensity conditioning for myelodysplastic syndrome;European Journal of Haematology;2020-03-09

2. Targeting High Mobility Group Box-1 (HMGB1) Promotes Cell Death in Myelodysplastic Syndrome;Clinical Cancer Research;2019-04-05

3. Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome;PLOS ONE;2017-09-27

4. Myelodysplastic syndromes;Clinical Manual of Blood and Bone Marrow Transplantation;2017-05-06

5. Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes;Bone Marrow Transplantation;2017-03-20